VIVAXIM
VIVAXIM
Discontinued
DIN Number
02248361
Drug Class
Human
Market Date
Nov 9, 2005
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02248361
AIG Number0249662001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA10 TYPHOID-HEPATITIS A
Product Specifications
Dosage FormSolution
,
Suspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
HEPATITIS A VACCINE, INACTIVATEDActive
Strength: 160 UNIT / 0.5 ML
Monograph: HEPATITIS A VACCINE, INACTIVATED
SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINEActive
Strength: 25 MCG / 0.5 ML
Monograph: SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE